S.R. Park

435 total citations
7 papers, 359 citations indexed

About

S.R. Park is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, S.R. Park has authored 7 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Gastroenterology. Recurrent topics in S.R. Park's work include Gastric Cancer Management and Outcomes (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). S.R. Park is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). S.R. Park collaborates with scholars based in South Korea and United States. S.R. Park's co-authors include C. G. Kim, Il Ju Choi, Young‐Woo Kim, J H Lee, Keun Won Ryu, Soo‐Jeong Cho, Seock‐Ah Im, Baek‐Yeol Ryoo, Jiyoung Rhee and Min‐Hee Ryu and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Surgical Oncology.

In The Last Decade

S.R. Park

6 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.R. Park South Korea	5	288	185	153	104	39	7	359
Heung-Moon Chang South Korea	9	170 0.6×	82 0.4×	149 1.0×	125 1.2×	24 0.6×	17	286
Kab Choong Kim South Korea	9	286 1.0×	192 1.0×	169 1.1×	127 1.2×	30 0.8×	12	363
Pauline Ries France	7	213 0.7×	106 0.6×	129 0.8×	142 1.4×	32 0.8×	18	306
Kevin K. Chang United States	6	202 0.7×	65 0.4×	103 0.7×	82 0.8×	48 1.2×	12	274
Tatsuo Yachida Japan	12	296 1.0×	210 1.1×	66 0.4×	249 2.4×	55 1.4×	65	433
Syoichi Fujii Japan	8	280 1.0×	102 0.6×	203 1.3×	195 1.9×	35 0.9×	12	446
Takaaki Hanyu Japan	11	244 0.8×	69 0.4×	60 0.4×	241 2.3×	42 1.1×	46	372
Pamela Dumas United States	8	516 1.8×	246 1.3×	254 1.7×	260 2.5×	61 1.6×	13	698
Soichi Tomimatsu Japan	8	270 0.9×	128 0.7×	122 0.8×	140 1.3×	99 2.5×	14	417
Cian Muldoon Ireland	9	241 0.8×	37 0.2×	133 0.9×	254 2.4×	23 0.6×	17	372

Countries citing papers authored by S.R. Park

Since Specialization

Citations

This map shows the geographic impact of S.R. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. Park more than expected).

Fields of papers citing papers by S.R. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. Park. The network helps show where S.R. Park may publish in the future.

Co-authorship network of co-authors of S.R. Park

This figure shows the co-authorship network connecting the top 25 collaborators of S.R. Park. A scholar is included among the top collaborators of S.R. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.R. Park. S.R. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Park, Se Hoon, Min‐Hee Ryu, Baek‐Yeol Ryoo, et al.. (2012). Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group. Investigational New Drugs. 30(6). 2377–2383. 86 indexed citations

2.

Park, S.R., Il Ju Choi, C. G. Kim, et al.. (2011). CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients. British Journal of Cancer. 104(7). 1126–1134. 47 indexed citations

3.

Eom, Bang Wool, Hong Man Yoon, Keun Won Ryu, et al.. (2011). Comparison of surgical performance and short-term clinical outcomes between laparoscopic and robotic surgery in distal gastric cancer. European Journal of Surgical Oncology. 38(1). 57–63. 84 indexed citations

4.

Han, Seung Woo, D-Y. Oh, S-A Im, et al.. (2009). Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. British Journal of Cancer. 100(2). 298–304. 121 indexed citations

5.

Park, S.R., C. G. Kim, Il Ju Choi, et al.. (2008). Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma. British Journal of Cancer. 98(8). 1305–1311. 19 indexed citations

6.

Park, S.R., et al.. (2007). CYP2A6 genetic polymorphism as a predictive marker for clinical outcomes in patients (pts) with metastastic gastric carcinoma (MGC) treated with S-1 plus docetaxel. Journal of Clinical Oncology. 25(18_suppl). 4633–4633. 2 indexed citations

7.

Park, S.R., Menggang Yu, C. G. Kim, et al.. (2006). A phase I study of S-1 plus weekly docetaxel in patients with metastatic gastric cancer. Journal of Clinical Oncology. 24(18_suppl). 14005–14005.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact